Liquid biopsy’s role in biomarker-driven NSCLC Management

Discover how Dr. Wade Iams of Vanderbilt University is utilizing liquid biopsy as a valuable tool for broad biomarker detection and monitoring resistance mechanisms to therapeutic pressure in NSCLC.

Apr 17, 2024
Providers
Webinar
Wade Iams, MDAssistant Professor of Medicine, Vanderbilt-Ingram Cancer Center
Gary I. Grad, MDSenior Medical Oncologist, Tempus
Ezra Cohen, MD FRCPSC, FASCOChief Medical Officer of Oncology, Tempus

Related content

Grey location pin icon with a white dot at its center, indicating a point on a map.Conference
Smooth vertical gradient transitioning from dark blue to light blue and white.

2026 ASCO® Annual Meeting

2026-04-13
Providers
Life Sciences
White square with a folded top-left corner on a dark background.Webinar
webinar_MRD-data-insights-across-the-cancer-care-continuum

From recurrence monitoring to treatment response: MRD data insights across the cancer care continuum

2026-05-11
Providers
Grey location pin icon with a white dot at its center, indicating a point on a map.Conference
Tempus_5

ACRP 2026 Annual Conference

2026-04-01
Providers
Life Sciences